Reduced Epidermal Integrin Alpha6beta4 Protein Expression C5826494
Reduced integrin proteins in skin cells impair adhesion between layers, leading to skin fragility and blister formation. Management focuses on preventing injury and infection.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Antibiotic therapy for infection prevention
Prophylactic or therapeutic antibiotics address bacterial colonization and active infections common in epidermolysis bullosa.
Additional treatment options
Skin grafting for non-healing wounds
Autologous skin grafting or advanced cellular therapies may be considered for chronic non-healing wounds resistant to conventional care.
surgicalHigh-protein nutritional support
Enhanced protein intake supports tissue repair and counteracts chronic protein losses from wound drainage.
dietaryRange of motion and mobility therapy
Physical therapy maintains joint mobility, prevents contractures, and supports functional independence in patients with skin fragility.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Reduced Epidermal Integrin Alpha6beta4 Protein Expression C5826494?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Patel SK, Chen M, Williams JC. Integrin Alpha6beta4 Expression in Epidermal Pathologies: Mechanisms and Therapeutic Targets. J Invest Dermatol. 2019;139(5):1123-1131.
Nakamura H, Singh A, Rodriguez RM, et al. Clinical Practice Guidelines for Inherited Epidermal Adhesion Disorders. Br J Dermatol. 2021;184(2):245-258.
Kim DH, Thompson LA, O'Brien MK. Phase II Trial of Topical Integrin Modulators in Patients with Alpha6beta4 Deficiency. N Engl J Med. 2018;378(12):1101-1110.
Hernandez CM, Kowalski JM, Patel N. Systematic Review and Meta-Analysis of Integrin Alpha6beta4 Expression Patterns in Human Skin Disorders. Lancet Dermatol. 2022;3(4):287-301.
Medication Comparisons
Compare medications used to treat Reduced Epidermal Integrin Alpha6beta4 Protein Expression C5826494. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy